You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 640 Combinatorial chemoimmunotherapy based on the antibody-cytokine fusion protein L19TNF unleashes potent anti-tumor immunity against treatment-refractory glioblastoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
640 Combinatorial chemoimmunotherapy based on the antibody-cytokine fusion protein L19TNF unleashes potent anti-tumor immunity against treatment-refractory glioblastoma
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to September 2024

AbstractFullPdf
Nov 2022406021
Dec 20228006
Jan 20236205
Feb 20233202
Mar 20236807
Apr 20233601
May 20239904
Jun 20238401
Jul 20233404
Aug 20232003
Sep 20233002
Oct 20237804
Nov 20237803
Dec 20236804
Jan 20244601
Feb 20242602
Mar 20245403
Apr 20248002
May 20246200
Jun 20243805
Jul 20242602
Aug 20245002
Sep 20243203
Total1589087